Working... Menu

Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02382588
Recruitment Status : Recruiting
First Posted : March 6, 2015
Last Update Posted : March 13, 2019
Bausch & Lomb Incorporated
Information provided by (Responsible Party):
Robert Feder, Northwestern University